osapiens raised €111M in a Series B round in Jul 2024. The company is based in Mannheim, Germany. Investors in the round: Growth Equity at Goldman Sachs Alternatives. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
